ProfileGDS4095 / 222139_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 63% 54% 58% 57% 55% 56% 52% 55% 49% 52% 53% 38% 53% 47% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep15.3514763
GSM709769LY2 SRC1-siRNA tamoxifen treated rep33.962554
GSM709765LY2 SRC1-siRNA untreated rep34.4299358
GSM709771LY2 SRC1-siRNA untreated rep14.290857
GSM709772LY2 SRC1-siRNA untreated rep24.1043555
GSM709775LY2 SRC1-siRNA untreated rep44.1927356
GSM709764LY2 control-siRNA tamoxifen treated rep23.7054352
GSM709766LY2 control-siRNA tamoxifen treated rep33.9732555
GSM709768LY2 control-siRNA tamoxifen treated rep13.4008249
GSM709777LY2 control-siRNA tamoxifen treated rep43.6503352
GSM709770LY2 control-siRNA untreated rep33.7560753
GSM709773LY2 control-siRNA untreated rep12.6596638
GSM709774LY2 control-siRNA untreated rep23.7237153
GSM709776LY2 control-siRNA untreated rep43.2395347